Intravenous: Clinical Trials

10 trials of Intravenous, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 3 unknown, 1 not yet recruiting. 3 Phase 2, 3 Phase 4, 2 Not applicable, 2 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Completed 1, Not yet recruiting 1, Unknown 1
Phase 43Completed 2, Unknown 1
Not applicable2Completed 2
Phase 32Completed 1, Unknown 1
Phase 11Unknown 1

Follow Intravenous: new trials by email Literature Review of Intravenous trials Research Report on Intravenous

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Neuroinduced Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Exosomes in Patients With Parkinsonism
Intrathecal (IT), Intravenous - Parkinsonism or Parkinson's Disease Nos, Parkinsonism in Diseases Classified Elsewhere
Phase 2Not yet recruitingBiocells Medical1202026-11-232026-03-13
Intravenous Vs. Intraosseous Vascular Access During Out-of-Hospital
Intraosseous access, Intravenous - Cardiac Arrest
Phase 4UnknownLars Wiuff Andersen14792022-03-012024-09-19
Intraosseous vs Intravenous Access for Cardiac Arrest Treatment
Intraosseous, Intravenous - Cardiac Arrest
Phase 4CompletedSingapore General Hospital11032014-06-012019-10-28
The Impact of Local Analgesia for Postoperative Analgesia in Posterior Thoracolumbar Operation
local, intravenous, 0.33% ropivacaine 250ml - Pain
Phase 4CompletedGuangzhou General Hospital of Guangzhou Military Command712013-05-012014-05-02
Transplantation of Autologous Adipose Derived Stem Cells (ADSCs) in Spinal Cord Injury Treatment
Laminectomy, Intradural space, Intrathecal - Acute Spinal Cord Injury
Phase 1 / Phase 2UnknownTri Phuoc Biotechnology., JSC482013-02-012014-01-13
Enteral Versus Intravenous Sedation in Critically Ill High-risk ICU Patients
Enteral Sedation (EN), Control group: Intravenous Sedation (IV) - Critical Illness, Mechanical Ventilation Complication
Phase 3UnknownUniversity of Milan3002012-01-012012-04-24
A Randomised Evaluation of Molecular Guided Therapy for Diffuse Large B-cell Lymphoma With Bortezomib
Intravenous, Bortezomib - Lymphoma, Large B-Cell, Diffuse
Phase 3CompletedUniversity Hospital Southampton NHS Foundation Trust11322011-04-012016-04-15
Randomized Trial of Intranasal Versus Intravenous Naloxone in Level of Consciousness in Suspected Opioid Overdose
Intranasal naloxone, Intravenous - Morphinan Opioid Overdose
Phase 2CompletedIsfahan University of Medical Sciences1002007-03-012011-02-10
Intravenous Alcohol Administration Using BrAc Method in Healthy Subjects With and Without a Family History of Alcoholism
Ethanol High Dose, Ethanol Low Dose, and Placebo - Alcoholism
Not applicableCompletedYale University1802001-03-012021-10-26
Ketamine/Placebo Family History Positive Study
Ketamine and Placebo - Alcoholism
Not applicableCompletedYale University992001-03-012021-10-06

Conditions studied

Alcoholism (2)  ·  Heart Arrest (2)  ·  Critical Illness (1)  ·  Drug Overdose (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Pain (1)  ·  Parkinson Disease (1)  ·  Parkinsonian Disorders (1)

Sponsors

Yale University (2)  ·  Biocells Medical (1)  ·  Guangzhou General Hospital of Guangzhou Military Command (1)  ·  Isfahan University of Medical Sciences (1)  ·  Lars Wiuff Andersen (1)  ·  Singapore General Hospital (1)  ·  Tri Phuoc Biotechnology., JSC (1)  ·  University Hospital Southampton NHS Foundation Trust (1)  ·  University of Milan (1)

Countries

United States (2)  ·  China (1)  ·  Denmark (1)  ·  Iran (1)  ·  Italy (1)  ·  Poland (1)  ·  Singapore (1)  ·  Switzerland (1)  ·  United Kingdom (1)  ·  Vietnam (1)

Top investigators

Hoa D Nguyen, MD (1)  ·  Iapichino Gaetano, MD (1)  ·  Ismene L Petrakis, MD (1)  ·  Ismene L. Petrakis, MD (1)  ·  Kenneth Boon Kiat Tan, MBBS (1)  ·  Nastaran Izadi, A.Professor (1)  ·  Phuc Ba Duong, MD (1)  ·  Prof Peter Johnson (1)

Results publications

PMID 18445106, PMID 20497133, PMID 23551983, PMID 30616675, PMID 30948276, PMID 36972491, PMID 39480221, PMID 40348355, PMID 41967754

NIH funding

P50AA012870 (2)